Biomarker A+T−: is this Alzheimer’s disease or not? A combined CSF and pathology study

Abstract The biological definition of Alzheimer’s disease using CSF biomarkers requires abnormal levels of both amyloid (A) and tau (T). However, biomarkers and corresponding cutoffs may not always reflect the presence or absence of pathology. Previous studies suggest that up to 32% of individuals w...

全面介紹

Saved in:
書目詳細資料
Main Authors: Eleonora M. Vromen, Sterre C.M. de Boer, Charlotte E. Teunissen, Annemieke J.M. Rozemüller, Anne Sieben, Maria Bjerke, Pieter Jelle Visser, Femke H. Bouwman, Sebastiaan Engelborghs, Betty M. Tijms
格式: Artigo
語言:英语
出版: 2022
在線閱讀:https://doi.org/10.1093/brain/awac158
https://academic.oup.com/brain/article-pdf/146/3/1166/49356410/awac158.pdf
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!